Abstract
The article analyzes the results of selective screening for the presence of antibodies to the core antigen of the hepatitis B virus in donors in Khabarovsk for the period 2021–2022 in accordance with the order of the Ministry of Health of the Russian Federation No. 1166n dated October 28, 2020. Hepatitis B virus core antigen was detected in 35 donors, which accounted for 14.5% of the number of studies and 0.07% of the total number of donors for 2021–2022. Investigation of blood samples of donors for the presence of antibodies to the core antigen of the hepatitis B virus makes it possible to identify infected HBsAg-negative donors and provides additional viral safety of blood transfusions
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Public health of the Far East Peer-reviewed scientific and practical journal
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
